ATE493128T1 - Behandlung von längenabhängiger neuropathie - Google Patents

Behandlung von längenabhängiger neuropathie

Info

Publication number
ATE493128T1
ATE493128T1 AT06837161T AT06837161T ATE493128T1 AT E493128 T1 ATE493128 T1 AT E493128T1 AT 06837161 T AT06837161 T AT 06837161T AT 06837161 T AT06837161 T AT 06837161T AT E493128 T1 ATE493128 T1 AT E493128T1
Authority
AT
Austria
Prior art keywords
painful
treatment
neuropathy
patients
compounds
Prior art date
Application number
AT06837161T
Other languages
English (en)
Inventor
James Campbell
Original Assignee
Arcion Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arcion Therapeutics Inc filed Critical Arcion Therapeutics Inc
Application granted granted Critical
Publication of ATE493128T1 publication Critical patent/ATE493128T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06837161T 2005-11-08 2006-11-07 Behandlung von längenabhängiger neuropathie ATE493128T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73442305P 2005-11-08 2005-11-08
PCT/US2006/043499 WO2007056460A2 (en) 2005-11-08 2006-11-07 Treatment of length dependent neuropathy

Publications (1)

Publication Number Publication Date
ATE493128T1 true ATE493128T1 (de) 2011-01-15

Family

ID=37946498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06837161T ATE493128T1 (de) 2005-11-08 2006-11-07 Behandlung von längenabhängiger neuropathie

Country Status (16)

Country Link
EP (2) EP2343068A3 (de)
JP (2) JP5044566B2 (de)
KR (1) KR101389184B1 (de)
CN (2) CN101365445A (de)
AT (1) ATE493128T1 (de)
AU (2) AU2006311580B2 (de)
CA (1) CA2628794C (de)
CY (1) CY1112190T1 (de)
DE (1) DE602006019311D1 (de)
DK (1) DK1962836T3 (de)
ES (1) ES2357033T3 (de)
HK (1) HK1123501A1 (de)
PL (1) PL1962836T3 (de)
PT (1) PT1962836E (de)
SI (1) SI1962836T1 (de)
WO (1) WO2007056460A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012012333A1 (en) * 2010-07-19 2012-01-26 Arcion Therapeutics, Inc. Topical treatment of neuropathic pain and methods of diagnosis
CN101947222A (zh) * 2010-08-18 2011-01-19 徐震 一种用于治疗高血压的软膏剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447947A (en) 1990-02-26 1995-09-05 Arc 1 Compositions and methods of treatment of sympathetically maintained pain
EP0573581A4 (en) * 1991-02-26 1994-06-29 Arc 1 Inc Compositions and methods of treatment of sympathetically maintained pain
DK0901790T3 (da) * 1997-09-16 2001-08-06 Solvay Pharm Gmbh Anvendelse af moxonidin til behandling af neuropatisk smerte
US6147102A (en) 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US7687080B2 (en) * 2002-11-25 2010-03-30 Taraxos Inc. Treatment of neuropathy
US20090325975A1 (en) * 2005-07-15 2009-12-31 Helmut H Buschmann Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain

Also Published As

Publication number Publication date
EP1962836B1 (de) 2010-12-29
CA2628794C (en) 2012-01-03
AU2006311580A1 (en) 2007-05-18
EP1962836A2 (de) 2008-09-03
ES2357033T3 (es) 2011-04-15
AU2010214659B2 (en) 2012-02-02
WO2007056460A2 (en) 2007-05-18
WO2007056460A3 (en) 2007-08-23
PT1962836E (pt) 2011-03-01
AU2006311580B2 (en) 2010-06-24
CY1112190T1 (el) 2015-12-09
KR101389184B1 (ko) 2014-04-24
DE602006019311D1 (de) 2011-02-10
JP5044566B2 (ja) 2012-10-10
JP2009514970A (ja) 2009-04-09
CN105147674A (zh) 2015-12-16
CA2628794A1 (en) 2007-05-18
DK1962836T3 (da) 2011-02-28
PL1962836T3 (pl) 2011-06-30
SI1962836T1 (sl) 2011-04-29
CN101365445A (zh) 2009-02-11
HK1123501A1 (en) 2009-06-19
EP2343068A2 (de) 2011-07-13
EP2343068A3 (de) 2012-06-13
KR20080091756A (ko) 2008-10-14
JP2012097121A (ja) 2012-05-24
AU2010214659A1 (en) 2010-09-16

Similar Documents

Publication Publication Date Title
JP4931128B2 (ja) Ｔｒｐｖ１アゴニストの投与のための方法および組成物
US6921529B2 (en) Treatment modality and method for fungal nail infection
BRPI0410169A (pt) dispositivo manual para aplicação de um material de barreira a uma mecha de cabelos; e método para aplicação de um material de barreira a uma mecha de cabelos a ser tratada
US20170112780A1 (en) Pharmaceutical composition for application to nail
RU2010123052A (ru) Авенантрамидсодержащие композиции
ATE384534T1 (de) Lösung zur nagel-verwendung
EA200301200A1 (ru) Проникающая через кожу композиция селективного ингибитора циклооксигеназы-2
JP2001354591A (ja) 爪甲真菌症処置の方法
US20040057919A1 (en) Antifungal composition and method for human nails
US20090215888A1 (en) Topical nail formulation
RU2009139896A (ru) Композиции по уходу за кожей, содержащие салициловую кислоту
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
HUE034680T2 (en) Transdermal pharmaceutical compositions containing SERM
ATE493128T1 (de) Behandlung von längenabhängiger neuropathie
GB2478159A (en) Composition for the treatment of fungal nail infection
FR2862062B1 (fr) Lipide a et composition topique, notamment cosmetique, le comprenant
DE602006005637D1 (de) Entpigmentisierende bzw. aufhellende kosmetikzusammensetzung, die mindestens ein oxazolin als wirkstoff umfasst
CA2495923A1 (en) Methods for treating fungal infections
AR045178A1 (es) Uso de un componente retinoide seleccionado entre el grupo formado por agentes retinoides activos, precursores de agentes retinoides activos y mezclas de los mismos, para preparar una composicion farmaceutica
BRPI0414112A (pt) uso de oxcarbazepina para o tratamento de dor neuropática diabética e a melhora do sono
JP6016085B2 (ja) 抗真菌外用組成物及び抗真菌外用組成物の適用方法
Salman et al. Feline mange: Diagnosis and therapeutic management of Notoedres cati
Ghosh et al. Studies of Ringworm. Part III. Prophylactic Measures
TH87784B (th) สูตรเฉพาะที่มี o-เดสเมทธิลเวนลาฟาซีน(odv)หรือเกลือของมัน
AR041767A1 (es) Composicion de aplicacion topica para el tratamiento de ectoparasitos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1962836

Country of ref document: EP